Step Therapy Requirements. Effective: 12/01/2016

Similar documents
ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS

Step Therapy Requirements. Effective: 1/1/2019

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

FirstCarolinaCare Insurance Company Step Therapy Requirements

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Step Therapy Requirements. Effective: 11/01/2018

Step Therapy Requirements. Effective: 05/01/2018

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

FirstCarolinaCare Insurance Company. Step Therapy Requirements

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

Step Therapy Requirements

Step Therapy Requirements. Effective: 03/01/2015

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

ALPHA GLUCOSIDASE INHIBITOR THERAPY

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

Step Therapy Group Algorithm Steps

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

SelectHealth Advantage 2018 Step Therapy Criteria. Previous trial on at least ONE: Generic topical acne treatment. Previous trial on: alendronate

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

ALLERGIC CONJUNCTIVITIS AGENTS

2017 Step Therapy Criteria

ARBS MEDICATION(S) SUBJECT TO STEP THERAPY DIOVAN HCT MG TAB, DIOVAN HCT MG TABLET

2018 Step Therapy Criteria

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

SelectHealth Advantage 2018 Step Therapy Criteria Previous trial on at least ONE: Generic topical acne treatment

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

Cigna Drug and Biologic Coverage Policy

ANTICONVULSANT THERAPY

ATYPICAL ANTIPSYCHOTICS

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

Formulary Medical Necessity Program

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

SmithRx Standard Formulary Step Therapy List

STEP THERAPY ALGORITHMS PUP Select Formulary

Commissioner for the Department for Medicaid Services Selections for Preferred Products

Fee-for-Service Pharmacy Provider Notice #216 ** March 2016 PDL Changes ** Existing Drug Classes

SelectHealth Advantage 2019 Step Therapy Criteria Previous trial on at least ONE: Generic topical acne treatment

OptumRx Focused Utilization Management Program

Prescription benefit updates Large group

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

2019 STEP THERAPY CRITERIA UCare Individual & Family Plans UCare Individual & Family Plans with Fairview

TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

Step Therapy. Here s how it works:

Before a Step 2 medication is covered You get a prescription

Aetna Better Health of Illinois Medicaid Formulary Updates

Step Therapy Criteria 2019

ADHD STIMULANTS-S(SHC)

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Step Therapy Approval Criteria

Step Therapy Medications

PharmaSuitables October Rich Price, MD Zach Kareus, Pharm.D. Steve Nolan, Pharm.D.

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

Save on your drugs with HealthyRx

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)

Step Therapy Approval Criteria

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

Your prescription benefit updates Formulary Updates - Effective January 1, 2019

ANTICONVULSANT STEP THERAPY

Quantity Limits 2016 Paramount Medicare Formulary Formulary ID: Version 26 Updated: 11/1/2016

Oregon Health Plan prescription benefit updates

Step Therapy Criteria

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

Step Therapy Criteria

2015 Chinese Community Health Plan Senior Program (HMO) Step Therapy Criteria Last Updated 11/1/2015

ANGIOTENSIN RECEPTOR BLOCKERS

Beneficiary Advisory Panel Handout Uniform Formulary Decisions 23 June 2011

Step Therapy Program Precision Formulary

MedPerform Medium Preferred Drug List (PDL)

AGGRENOX. Products Affected. Details. Open 1 Last Updated: 10/01/2018. Aggrenox

PHARMACY AND THERAPEUTICS COMMITTEE August 2016

Step Therapy Requirements

ADHD STIMULANTS - SCORE

Transcription:

Effective: 12/01/2016 H2986_PD_049 Updated 11/2016

ALPHA 1-PROTEINASE INHIBITOR GLASSIA PRIOR CLAIM FOR ARALAST NP OR ZEMAIRA WITHIN THE PAST 120 DAYS.

ANALGESICS, NARCOTICS KADIAN MORPHINE SULFATE ER PRIOR CLAIM FOR MORPHINE SULFATE SUSTAINED ACTION TABLET (MS CONTIN) WITHIN THE PAST 120 DAYS.

ANTI-INFLAMMATORY AGENTS - GI DIPENTUM GIAZO LIALDA PENTASA PRIOR CLAIM FOR ANY 1 OF THE FOLLOWING: DELZICOL, ASACOL, MESALAMINE 800MG DR TAB, BALSALAZIDE OR APRISO WITHIN THE PAST 120 DAYS

ANTIBACTERIALS (EENT) BESIVANCE PRIOR CLAIM FOR CIPROFLOXACIN OPHTHALMIC DROPS, CIPROFLOXACIN OPHTHALMIC OINTMENT, OR OFLOXACIN OPHTHALMIC DROPS WITHIN THE LAST 120 DAYS.

ANTIDIABETIC AGENTS - INSULINS LEVEMIR LEVEMIR FLEXTOUCH PRIOR CLAIM FOR INSULIN GLARGINE (LANTUS OR LANTUS SOLOSTAR OR TOUJEO) WITHIN THE PAST 120 DAYS.

ANTIDIABETIC AGENTS - MISCELLANEOUS GLYXAMBI INVOKAMET INVOKANA JARDIANCE SYNJARDY PRIOR CLAIM FOR METFORMIN, METFORMIN ER, A SULFONYLUREA AGENT (GLYBURIDE, GLIPIZIDE, GLIMEPIRIDE, TOLAZAMIDE, TOLBUTAMIDE), COMBINATION OF A SULFONYLUREA-METFORMIN, PIOGLITAZONE, OR A COMBINATION PIOGLITAZONE-METFORMIN OR PIOGLITAZONE- GLIMEPIRIDE WITHIN THE PAST 120 DAYS.

ANTIDIABETIC AGENTS - SGLT-2 FARXIGA XIGDUO XR PRIOR CLAIM FOR INVOKANA OR INVOKAMET OR JARDIANCE OR SYNJARDY AND METFORMIN, METFORMIN ER, A SULFONYLUREA AGENT (GLYBURIDE, GLIPIZIDE, GLIMEPIRIDE), COMBINATION OF A SULFONYLUREA-METFORMIN, PIOGLITAZONE, OR A COMBINATION PIOGLITAZONE-METFORMIN OR PIOGLITAZONE- GLIMEPIRIDE WITHIN THE PAST 365 DAYS.

ANTIPSYCHOTIC AGENTS CLOZAPINE ODT FANAPT FAZACLO SAPHRIS VERSACLOZ PRIOR CLAIM FOR FORMULARY VERSIONS OF ANTIPSYCHOTICS RISPERIDONE TABLET, RISPERIDONE DISINTEGRATING TABLET, CLOZAPINE TABLET, OLANZAPINE TABLET, OLANZAPINE ORAL DISINTEGRATING TABLET, IMMEDIATE RELEASE QUETIAPINE FUMARATE, OR ZIPRASIDONE, AND ABILIFY OR ARIPIPRAZOLE WITHIN THE PAST 365 DAYS.

ANTIULCER AGENTS DEXILANT ESOMEPRAZOLE MAGNESIUM ESOMEPRAZOLE STRONTIUM NEXIUM PREVACID PRIOR CLAIM FOR GENERIC FEDERAL LEGEND OMEPRAZOLE, PANTOPRAZOLE, OR LANSOPRAZOLE WITHIN THE PAST 120 DAYS.

B VERSUS D ADMINISTRATIVE STEP CYCLOPHOSPHAMIDE METHOTREXATE RHEUMATREX TREXALL IN ORDER TO ASSIST IN A PART B VS. D PAYMENT DETERMINATION, A PRIOR CLAIM SEEN FOR A RHEUMATOID ARTHRITIS, PSORIASIS OR ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS DRUG WITHIN THE PAST 120 DAYS WILL QUALIFY FOR PART D PAYMENT. ALL OTHER INDICATIONS WILL HAVE A PART B VS. D PAYMENT DETERMINATION MADE THROUGH THE FORMULARY EXCEPTION PROCESS PRIOR TO THE APPROVAL OF THE DRUG.

BELBUCA BELBUCA PRIOR CLAIM FOR BUTRANS PATCH WITHIN THE PAST 120 DAYS.

BUDESONIDE - UCERIS UCERIS PRIOR CLAIM FOR BALSALAZIDE WITHIN THE PAST 120 DAYS.

BUDESONIDE-FORMOTEROL FUMARATE SYMBICORT PRIOR CLAIM FOR ADVAIR OR DULERA WITHIN THE PAST 120 DAYS.

COPD II INCRUSE ELLIPTA SEEBRI NEOHALER PRIOR CLAIM FOR SPIRIVA WITHIN THE PAST 120 DAYS.

COPD III UTIBRON NEOHALER PRIOR CLAIM FOR STIOLTO WITHIN THE PAST 120 DAYS.

ELUXADOLINE VIBERZI PRIOR CLAIM FOR DICYCLOMINE AND XIFAXAN 550MG WITHIN THE PAST 120 DAYS.

FACTOR XA INHIBITORS PRADAXA PRIOR CLAIM FOR ELIQUIS AND XARELTO IN THE PAST 365 DAYS.

GAPABENTIN SR GRALISE PRIOR CLAIM FOR GABAPENTIN IMMEDIATE RELEASE WITHIN THE PAST 120 DAYS.

GLP-1 ANALOGS II BYDUREON BYDUREON PEN BYETTA TANZEUM PRIOR CLAIM FOR VICTOZA OR TRULICITY AND EITHER METFORMIN, METFORMIN ER, A SULFONYLUREA AGENT (GLYBURIDE, GLIPIZIDE, GLIMEPIRIDE), COMBINATION OF A SULFONYLUREA- METFORMIN, PIOGLITAZONE, OR A COMBINATION PIOGLITAZONE-METFORMIN OR PIOGLITAZONE-GLIMEPIRIDE WITHIN THE PAST 365 DAYS.

IVABRADINE CORLANOR PRIOR CLAIM FOR METOPROLOL SUCCINATE, BISOPROLOL OR CARVEDILOL WITHIN THE PAST 120 DAYS.

MULTIPLE SCLEROSIS AGENTS AVONEX AVONEX PEN BETASERON EXTAVIA PLEGRIDY PLEGRIDY PEN PRIOR CLAIM FOR REBIF (INTERFERON BETA-1A) OR FORMULARY GLATIRAMER ACETATE WITHIN THE PAST 120 DAYS.

MULTIPLE SCLEROSIS AGENTS II ZINBRYTA PRIOR CLAIM FOR TWO FORMULARY MULTIPLE SCLEROSIS AGENTS: AUBAGIO, AVONEX, BETASERON, EXTAVIA, FORMULARY GLATIRAMER ACETATE, GILENYA, MITOXANTRONE, PLEGRIDY, REBIF, TECFIDERA AND TYSABRI.

OPHTHALMIC ANTIHISTAMINES ALREX BEPREVE ELESTAT EMADINE LASTACAFT PATADAY PATANOL PAZEO PRIOR CLAIM FOR LEVOCETIRIZINE OR CROMOLYN SODIUM EYE DROPS, EPINASTINE, OLOPATADINE 0.1% EYE DROPS WITHIN THE PAST 120 DAYS.

ORAL INHALED CORTICOSTEROID II AEROSPAN PRIOR CLAIM FOR QVAR AND FLOVENT WITHIN THE PAST 365 DAYS.

ORAL INHALED CORTICOSTEROIDS ALVESCO ARNUITY ELLIPTA ASMANEX PULMICORT FLEXHALER PRIOR CLAIM FOR QVAR WITHIN THE PAST 120 DAYS.

QUETIAPINE FUMARATE EXTENDED RELEASE SEROQUEL XR PRIOR CLAIM FOR FORMULARY VERSIONS OF ATYPICAL ANTIPSYCHOTICS: RISPERIDONE TABLET, RISPERIDONE DISINTEGRATING TABLET, CLOZAPINE TABLET, OLANZAPINE TABLET, OLANZAPINE ORAL DISINTEGRATING TABLET, IMMEDIATE RELEASE QUETIAPINE FUMARATE, ZIPRASIDONE,CITALOPRAM, FLUOXETINE, PAROXETINE, SERTRALINE, DULOXETINE, VENLAFAXINE, AND ARIPIPRAZOLE WITHIN THE PAST 365 DAYS.

RENIN ANGIOTENSION SYSTEM INHIBITORS ATACAND ATACAND HCT AVALIDE AVAPRO DIOVAN DIOVAN HCT EDARBI EDARBYCLOR EXFORGE EXFORGE HCT MICARDIS MICARDIS HCT TEKTURNA TEKTURNA HCT TWYNSTA PRIOR CLAIM FOR AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR (ACE INHIBITOR), OR ACE INHIBITOR COMBINATION OR A GENERIC ANGIOTENSIN RECEPTOR BLOCKER (ARB), OR GENERIC ARB COMBINATION WITHIN THE PAST 120 DAYS.

SPRITAM SPRITAM PRIOR CLAIM FOR LEVETIRACETAM SOLUTION IN THE PAST 120 DAYS

VIVLODEX VIVLODEX PRIOR CLAIM FOR GENERIC MELOXICAM 7.5MG OR 15MG TABLETS WITHIN THE PAST 120 DAYS.